SEC Form 4 · accession 0001144204-17-044236

Accelerate Diagnostics, Inc · AXDX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Lawrence Mehren

Officer — PRESIDENT AND CEO · Director

Period of report

Aug 17, 2017

Accepted (ET)

Aug 18, 2017 · 6:48 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000727207

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Aug 17, 2017	S	223,215	$22.40	D	762,381	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F2	$12.49	holding	—	—	—	Mar 18, 2017	Mar 18, 2026	Common Stock	—	10,408	D
Employee Stock Option (right to buy)^F3,F2	$12.49	holding	—	—	—	—	Mar 18, 2026	Common Stock	—	60,000	D
Employee Stock Option (right to buy)^F2	$14.92	holding	—	—	—	Feb 26, 2015	Feb 26, 2024	Common Stock	—	52,132	D
Employee Stock Option (right to buy)^F4,F2	$1.04	holding	—	—	—	—	Apr 20, 2022	Common Stock	—	2,200,000	D

Explanation of responses

F1The reporting person contributed AXDX common stock to an exchange fund in exchange for shares of the exchange fund. The AXDX common stock was valued at $22.40 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person. The shares were contributed pursuant to a Rule 10b5-1 plan entered into by the reporting person.
F2No transaction is being reported at this time. This line is only reporting holdings as of the date hereof.
F3The options vest in five (5) equal annual installments on each annivesary of the date of grant beginning on March 18, 2017.
F4580,000 shares vested immediately upon the date of grant (April 20, 2012); 825,000 shares will vest as follows: 40% (330,000 shares) will vest on the second anniversary of the date of grant, and the remaining 60% (495,000 shares) will vest in 36 equal monthly installments (13,750 shares per month) over the subsequent 36 months; and 795,000 shares will vest as follows (provided that both criteria must be satisfied): (i) 40% (318,000 shares) will vest on the second anniversary of the date of grant, and the remaining 60% (477,000 shares) will vest in 36 equal monthly installments (13,250 shares per month) over the subsequent 36 months, and (ii) 50% (397,500 shares) will vest when at least 50% of the warrants initially issued to Abeja have been exercised by the holder(s) thereof, and the remaining 50% (397,500 shares) will vest when at least 90% of such warrants have been exercised by the holder(s) thereof.